Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g
- PMID: 12003608
- DOI: 10.1001/archopht.120.5.595
Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g
Abstract
Objective: To present ophthalmological outcome data at 5(1/2) years after full term from a natural history cohort of infants who had a birth weight less than 1251 g and were enrolled at 5 centers of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (ROP), including eyes without ROP and with a full range of ROP severity.
Design: Of the 1199 surviving children in the cohort, 1068 (89.1%) were examined. Study-certified ophthalmologists assessed ROP residua and conducted cycloplegic refractions. Visual acuity was measured by study-trained testers using the Early Treatment for Diabetic Retinopathy Study charts. Eyes that had developed ROP were categorized by the lowest (most posterior) zone and highest (most severe) stage reached during the acute phase of the disease. No eyes that received cryotherapy are included; data analysis included one untreated eye per patient. Fundus outcomes were classified as "unfavorable" if there was macular compromise by retinal folding (more severe than ectopia) or stage 4B or 5 retinal detachment. Visual acuity outcomes of 20/200 or worse were classified as unfavorable.
Results: Unfavorable fundus structural outcome occurred in 33 (3.1%) of the 1068 eyes; all 33 eyes had a history of severe ROP. Specifically, unfavorable fundus structure occurred in 62.5% (10/16) of eyes with zone I ROP and in 44.2% (23/52) of eyes with zone II ROP, stage 3+ disease involving more than six 30 degrees -sectors. There were no unfavorable fundus outcomes among eyes that had fewer than 7 clock-hours of stage 3+ ROP in zone II in this cohort. Snellen visual acuity was tested in 1059 eyes, and 5.1% were unfavorable at 20/200 or worse; these unfavorable outcomes were correlated with more severe ROP. In eyes that had zone I ROP, 68.8% (11/16) had unfavorable acuity, and for eyes that had zone II ROP, 7.5% (36/481) had unfavorable acuity results. For eyes with ROP observed only in zone III, 1.8% (2/110) had unfavorable acuity of 20/200 or worse.
Conclusions: Premature infants with birth weights less than 1251 g seldom have poor structural and functional outcomes (3.1% and 5.1%, respectively). All unfavorable fundus structural outcomes and nearly all unfavorable acuity outcomes occurred in eyes with zone I ROP or zone II ROP involving more than 6 sectors of stage 3+ disease.
Similar articles
-
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.Arch Ophthalmol. 2001 Aug;119(8):1110-8. doi: 10.1001/archopht.119.8.1110. Arch Ophthalmol. 2001. PMID: 11483076 Clinical Trial.
-
Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization.Arch Ophthalmol. 1996 Apr;114(4):417-24. doi: 10.1001/archopht.1996.01100130413008. Arch Ophthalmol. 1996. PMID: 8602778 Clinical Trial.
-
The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group.Arch Ophthalmol. 1994 Jul;112(7):903-12. doi: 10.1001/archopht.1994.01090190051021. Arch Ophthalmol. 1994. PMID: 8031269 Clinical Trial.
-
Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP).Doc Ophthalmol. 1990 Mar;74(3):245-51. doi: 10.1007/BF02482615. Doc Ophthalmol. 1990. PMID: 2209383 Review.
-
Long term functional and structural outcomes of laser therapy for retinopathy of prematurity.Br J Ophthalmol. 2006 Jun;90(6):754-9. doi: 10.1136/bjo.2005.068304. Br J Ophthalmol. 2006. PMID: 16714267 Free PMC article. Review.
Cited by
-
Laser treatment for retinopathy of prematurity.Lasers Med Sci. 2013 Feb;28(2):683-92. doi: 10.1007/s10103-011-1021-z. Epub 2011 Dec 2. Lasers Med Sci. 2013. PMID: 22134790 Review.
-
A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.Trans Am Ophthalmol Soc. 2006;104:78-84. Trans Am Ophthalmol Soc. 2006. PMID: 17471328 Free PMC article.
-
Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.Mol Vis. 2008 Feb 11;14:345-57. Mol Vis. 2008. PMID: 18334951 Free PMC article.
-
Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management.Arch Ophthalmol. 2008 Apr;126(4):493-9. doi: 10.1001/archopht.126.4.493. Arch Ophthalmol. 2008. PMID: 18413518 Free PMC article.
-
Lens-sparing vitrectomy for stage 4 and stage 5 retinopathy of prematurity.Korean J Ophthalmol. 2006 Jun;20(2):113-7. doi: 10.3341/kjo.2006.20.2.113. Korean J Ophthalmol. 2006. PMID: 16892648 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources